Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study seeks to compare dexamethasone implant with rescue intravitreal ranibizumab to
monthly intravitreal ranibizumab for the treatment of macular edema secondary to branch or
central retinal vein occlusion. This is based on the null hypothesis that dexamethasone
implant with rescue ranibizumab has inferior best corrected visual acuity at six months
compared to monthly ranibizumab alone.